×
S&P 500   3,845.08 (+0.36%)
DOW   31,037.68 (+0.23%)
QQQ   288.74 (+0.62%)
AAPL   142.80 (+0.88%)
MSFT   266.14 (+1.25%)
META   169.77 (+0.94%)
GOOGL   2,291.11 (+1.14%)
AMZN   114.26 (+0.67%)
TSLA   694.30 (-0.70%)
NVDA   151.30 (+1.11%)
NIO   20.81 (-6.18%)
BABA   119.25 (-0.73%)
AMD   75.37 (+0.23%)
MU   57.37 (+1.13%)
CGC   2.65 (-2.21%)
T   21.09 (-0.38%)
GE   61.56 (-0.76%)
F   11.07 (-1.16%)
DIS   96.11 (-1.10%)
AMC   12.58 (-1.56%)
PFE   52.75 (+2.15%)
PYPL   73.24 (-1.56%)
NFLX   184.06 (-0.98%)
S&P 500   3,845.08 (+0.36%)
DOW   31,037.68 (+0.23%)
QQQ   288.74 (+0.62%)
AAPL   142.80 (+0.88%)
MSFT   266.14 (+1.25%)
META   169.77 (+0.94%)
GOOGL   2,291.11 (+1.14%)
AMZN   114.26 (+0.67%)
TSLA   694.30 (-0.70%)
NVDA   151.30 (+1.11%)
NIO   20.81 (-6.18%)
BABA   119.25 (-0.73%)
AMD   75.37 (+0.23%)
MU   57.37 (+1.13%)
CGC   2.65 (-2.21%)
T   21.09 (-0.38%)
GE   61.56 (-0.76%)
F   11.07 (-1.16%)
DIS   96.11 (-1.10%)
AMC   12.58 (-1.56%)
PFE   52.75 (+2.15%)
PYPL   73.24 (-1.56%)
NFLX   184.06 (-0.98%)
S&P 500   3,845.08 (+0.36%)
DOW   31,037.68 (+0.23%)
QQQ   288.74 (+0.62%)
AAPL   142.80 (+0.88%)
MSFT   266.14 (+1.25%)
META   169.77 (+0.94%)
GOOGL   2,291.11 (+1.14%)
AMZN   114.26 (+0.67%)
TSLA   694.30 (-0.70%)
NVDA   151.30 (+1.11%)
NIO   20.81 (-6.18%)
BABA   119.25 (-0.73%)
AMD   75.37 (+0.23%)
MU   57.37 (+1.13%)
CGC   2.65 (-2.21%)
T   21.09 (-0.38%)
GE   61.56 (-0.76%)
F   11.07 (-1.16%)
DIS   96.11 (-1.10%)
AMC   12.58 (-1.56%)
PFE   52.75 (+2.15%)
PYPL   73.24 (-1.56%)
NFLX   184.06 (-0.98%)
S&P 500   3,845.08 (+0.36%)
DOW   31,037.68 (+0.23%)
QQQ   288.74 (+0.62%)
AAPL   142.80 (+0.88%)
MSFT   266.14 (+1.25%)
META   169.77 (+0.94%)
GOOGL   2,291.11 (+1.14%)
AMZN   114.26 (+0.67%)
TSLA   694.30 (-0.70%)
NVDA   151.30 (+1.11%)
NIO   20.81 (-6.18%)
BABA   119.25 (-0.73%)
AMD   75.37 (+0.23%)
MU   57.37 (+1.13%)
CGC   2.65 (-2.21%)
T   21.09 (-0.38%)
GE   61.56 (-0.76%)
F   11.07 (-1.16%)
DIS   96.11 (-1.10%)
AMC   12.58 (-1.56%)
PFE   52.75 (+2.15%)
PYPL   73.24 (-1.56%)
NFLX   184.06 (-0.98%)
NASDAQ:TGTX

TG Therapeutics SEC Filings & 10K Form

$5.30
+0.05 (+0.95%)
(As of 07/6/2022 03:59 PM ET)
Add
Compare
Today's Range
$5.10
$5.51
50-Day Range
$3.74
$7.86
52-Week Range
$3.48
$40.66
Volume
284,632 shs
Average Volume
3.43 million shs
Market Capitalization
$765.48 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$21.25

Recent TG Therapeutics SEC Filings

DateFilerForm TypeView
06/24/2022
4:10 PM
TG Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
06/23/2022
3:31 PM
TG Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/10/2022
3:31 PM
TG Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/29/2022
3:11 PM
TG Therapeutics (Filer)
Form DEFA14A
04/18/2022
6:30 AM
TG Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/06/2021
4:01 PM
TG Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/02/2021
6:12 AM
TG Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/22/2021
5:27 PM
Power Sean A (Reporting)
TG Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/22/2021
5:26 PM
TG Therapeutics (Issuer)
WEISS MICHAEL S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/22/2021
5:26 PM
Lonial Sagar (Reporting)
TG Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/22/2021
5:26 PM
HUME DANIEL (Reporting)
TG Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/22/2021
5:25 PM
Hoberman Kenneth (Reporting)
TG Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/22/2021
5:25 PM
Echelard Yann (Reporting)
TG Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/22/2021
5:25 PM
Charney Laurence N (Reporting)
TG Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2021
4:29 PM
TG Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/10/2021
6:23 AM
TG Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/20/2021
4:00 PM
TG Therapeutics (Filer)
Form PRE 14A
04/16/2021
6:53 AM
TG Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/13/2021
3:30 PM
TG Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/02/2021
6:07 AM
TG Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/10/2021
3:49 PM
RA CAPITAL MANAGEMENT, L.P. (Filed by)
TG Therapeutics (Subject)
Form SC 13G/A
02/10/2021
3:34 PM
RA CAPITAL MANAGEMENT, L.P. (Filed by)
TG Therapeutics (Subject)
Form SC 13G/A
02/08/2021
9:33 AM
FMR LLC (Filed by)
TG Therapeutics (Subject)
Form SC 13G/A
02/08/2021
6:01 AM
TG Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/01/2021
7:30 AM
BlackRock Inc. (Filed by)
TG Therapeutics (Subject)
Form SC 13G/A
01/04/2021
3:30 PM
Power Sean A (Reporting)
TG Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/31/2020
3:30 PM
TG Therapeutics (Issuer)
WEISS MICHAEL S (Reporting)
Form 5
Annual statement of changes in beneficial ownership of securities  
12/16/2020
3:16 PM
TG Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/16/2020
3:11 PM
TG Therapeutics (Filer)
Form 424B5
12/14/2020
7:09 AM
TG Therapeutics (Filer)
Form 424B5
12/10/2020
6:50 AM
TG Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/08/2020
7:00 AM
TG Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/09/2020
4:29 PM
TG Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/09/2020
4:25 PM
TG Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/09/2020
4:13 PM
TG Therapeutics (Filer)
Form 424B5
11/09/2020
4:04 PM
TG Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/04/2020
7:50 PM
TG Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/11/2020
3:31 PM
Kolchinsky Peter (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
Shah Rajeev M. (Reporting)
TG Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/10/2020
6:30 AM
TG Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/20/2020
6:00 PM
Power Sean A (Reporting)
TG Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2020
3:32 PM
Lonial Sagar (Reporting)
TG Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2020
3:31 PM
Lonial Sagar (Reporting)
TG Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
06/24/2020
6:51 PM
TG Therapeutics (Issuer)
WEISS MICHAEL S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2020
6:50 PM
HUME DANIEL (Reporting)
TG Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2020
6:50 PM
Hoberman Kenneth (Reporting)
TG Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2020
6:49 PM
Echelard Yann (Reporting)
TG Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2020
6:49 PM
Charney Laurence N (Reporting)
TG Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2020
6:48 PM
KENNEDY WILLIAM JAMES (Reporting)
TG Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2020
4:00 PM
TG Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/10/2020
9:13 AM
FMR LLC (Filed by)
TG Therapeutics (Subject)
Form SC 13G
05/29/2020
10:16 AM
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM (Filed by)
TG Therapeutics (Subject)
Form PX14A6G
05/14/2020
4:18 PM
TG Therapeutics (Filer)
Form 424B5
05/11/2020
4:16 PM
TG Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/11/2020
4:09 PM
TG Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/07/2020
3:30 PM
Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
Shah Rajeev M. (Reporting)
TG Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
05/05/2020
6:30 AM
TG Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/30/2020
6:31 AM
TG Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/20/2020
3:54 PM
TG Therapeutics (Filer)
Form 424B5
03/20/2020
3:39 PM
TG Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/03/2020
6:22 AM
TG Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/02/2020
3:31 PM
TG Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/14/2020
8:57 AM
Avoro Capital Advisors LLC (Filed by)
TG Therapeutics (Subject)
Form SC 13G/A
01/24/2020
3:11 PM
INTEGRATED CORE STRATEGIES LLC (0001319244) (Filed by)
TG Therapeutics (Subject)
Form SC 13G/A
01/02/2020
12:23 PM
GREAT POINT PARTNERS LLC (Filed by)
TG Therapeutics (Subject)
Form SC 13G
12/26/2019
7:46 AM
TG Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/23/2019
6:39 AM
TG Therapeutics (Filer)
Form 424B5
12/09/2019
7:15 AM
TG Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/12/2019
4:27 PM
TG Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/12/2019
6:39 AM
TG Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/28/2019
6:59 AM
TG Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/18/2019
4:11 PM
Hoberman Kenneth (Reporting)
TG Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/18/2019
4:10 PM
Charney Laurence N (Reporting)
TG Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/18/2019
4:09 PM
Echelard Yann (Reporting)
TG Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/18/2019
4:09 PM
KENNEDY WILLIAM JAMES (Reporting)
TG Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/18/2019
4:09 PM
HUME DANIEL (Reporting)
TG Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/12/2019
8:25 AM
TG Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/05/2019
3:17 PM
TG Therapeutics (Filer)
Form S-3ASR
09/05/2019
3:00 PM
TG Therapeutics (Filer)
Form RW
08/30/2019
3:16 PM
TG Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
08/09/2019
3:31 PM
TG Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/09/2019
6:33 AM
TG Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/03/2019
3:00 PM
Power Sean A (Reporting)
TG Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2019
6:33 AM
TG Therapeutics (Issuer)
WEISS MICHAEL S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2019
3:43 PM
TG Therapeutics (Issuer)
WEISS MICHAEL S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2019
3:07 PM
TG Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/31/2019
1:48 PM
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM (Filed by)
TG Therapeutics (Subject)
Form PX14A6G
05/10/2019
3:01 PM
TG Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/10/2019
6:01 AM
TG Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/30/2019
3:35 PM
TG Therapeutics (Filer)
Form DEFA14A
04/01/2019
7:33 AM
TG Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/11/2019
3:06 PM
BRIDGER MANAGEMENT, LLC (Filed by)
TG Therapeutics (Subject)
Form SC 13G
03/05/2019
8:01 AM
TG Therapeutics (Filer)
Form 424B5
03/05/2019
8:00 AM
TG Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/28/2019
3:02 PM
TG Therapeutics (Filer)
Form 424B5
02/28/2019
6:33 AM
TG Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2019
4:14 PM
RA CAPITAL MANAGEMENT, LLC (Filed by)
TG Therapeutics (Subject)
Form SC 13G
02/14/2019
7:42 AM
STATE STREET CORP (Filed by)
TG Therapeutics (Subject)
Form SC 13G
02/14/2019
7:22 AM
TG Therapeutics (Subject)
venBio Select Advisor LLC (Filed by)
Form SC 13G
02/13/2019
11:06 AM
FMR LLC (Filed by)
TG Therapeutics (Subject)
Form SC 13G/A
01/22/2019
7:07 AM
TG Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
This page (NASDAQ:TGTX) was last updated on 7/6/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.